Former President, Corporate and Product Strategy · Moderna, Inc. (MRNA)

John Mendlein

FY2018 is the first fiscal year CompBrief holds for John Mendlein as a named executive officer of Moderna; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$26,163,117

Salary $500,000Stock awards $0Bonus $400,000

2nd of 4 named executive officers at Moderna by FY2018 total.

4 named officers on file for Moderna, FY2018

John Mendlein’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • MRNA’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Moderna’s whole pay program stands against its peers

  • Moderna’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRNA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 15, 2019 (DEF 14A).

Free

Get John Mendlein’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

John Mendlein compensation by year

Moderna Summary Compensation Table · the one fiscal year held
In US dollars, as Moderna reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$500,000
Bonus$400,000
Stock awards$0
Option awards$25,254,584
Non-equity incentive$0
Pension and deferred compensation$0
All other$8,533
Total$26,163,117

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Moderna, Inc. DEF 14A filed May 15, 2019, accession 0001193125-19-148153, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Moderna, Inc. filed document, accession 0001193125-19-148153. Every figure is read from that document and cited to the page and table it appears in. Filed May 15, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option2,981,651—$14.22

Per the Outstanding Equity Awards at Fiscal Year-End table in Moderna, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Moderna’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Stéphane BancelChief Executive Officer$58,608,484
John Mendlein · this pageFormer President, Corporate and Product Strategy$26,163,117
Lorence KimFormer Chief Financial Officer$9,038,117
Stephen HogePresident$4,726,274

The full Moderna compensation record

free company brief

This page is one person within Moderna's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Moderna proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Moderna's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Mendlein's compensation dossier · One-time report. No refunds.